In vitro activities of ravuconazole and four other antifungal agents against fluconazole-resistant or -susceptible clinical yeast isolates

被引：41

作者：

Cuenca-Estrella, M ^{[1
]}

Gomez-Lopez, A ^{[1
]}

Mellado, E ^{[1
]}

Garcia-Effron, G ^{[1
]}

Rodriguez-Tudela, JL ^{[1
]}

机构：

[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Micol, Majadahonda 28220, Madrid, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 08期

关键词：

D O I：

10.1128/AAC.48.8.3107-3111.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The activities of ravuconazole and four other antifungal agents were tested against a collection of 1,796 clinical yeast isolates, including fluconazole-susceptible and -resistant strains. Ravuconazole was active against the majority of fluconazole-resistant isolates; but for 102 of 562 (18%) resistant isolates, mainly Candida tropicalis, Candida glabrata, and Cryptococcus neoformans, ravuconazole MICs were greater than or equal to1 mug/ml.

引用

页码：3107 / 3111

页数：5

共 29 条

[1] In vivo pharmacodynamics of a new triazole, ravulconazole, in a murine candidiasis model [J].

Andes, D ;

Marchillo, K ;

Stamstad, T ;

Conklin, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) :1193-1199

[2]

Arikan Sevtap, 2002, Curr Opin Investig Drugs, V3, P555

[3] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents [J].

Barry, AL ;

Pfaller, MA ;

Brown, SD ;

Espinel-Ingroff, A ;

Ghannoum, MA ;

Knapp, C ;

Rennie, RP ;

Rex, JH ;

Rinaldi, MG .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3457-3459

[4] Comparison among air pollutants, meteorological conditions and some chemical parameters in the transplanted lichen Usnea amblyoclada [J].

Carreras, HA ;

Pignata, ML .

ENVIRONMENTAL POLLUTION, 2001, 111 (01) :45-52

[5] Efficacy of ravuconazole in treatment of systemic murine histoplasmosis [J].

Clemons, KV ;

Martinez, M ;

Calderon, L ;

Stevens, DA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (03) :922-924

[6] Efficacy of ravueonazole in treatment of mucosal candidosis in SCID mice [J].

Clemons, KV ;

Stevens, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3433-3436

[7] Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species [J].

Cuenca-Estrella, M ;

Lee-Yang, W ;

Ciblak, MA ;

Arthington-Skaggs, BA ;

Mellado, E ;

Warnock, DW ;

Rodriguez-Tudela, JL .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3644-3647

[8] Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi [J].

Diekema, DJ ;

Messer, SA ;

Hollis, RJ ;

Jones, RN ;

Pfaller, MA .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) :3623-3626

[9] Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.:: NCCLS Collaborative Study [J].

Espinel-Ingroff, A ;

Fothergill, A ;

Peter, J ;

Rinaldi, MG ;

Walsh, TJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) :3204-3208

[10] In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole [J].

Fung-Tomc, JC ;

White, TC ;

Minassian, B ;

Huczko, E ;

Bonner, DP .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1999, 35 (02) :163-167

← 1 2 3 →